Advertisement

Topics

Daiichi, Merck subsidiary partner on breast, lung cancer R&D

05:41 EDT 21 Sep 2018 | SmartBrief

Daiichi Sankyo and a subsidiary of Merck, known as MSD outside North America, agreed to work together to develop the former's -More

Original Article: Daiichi, Merck subsidiary partner on breast, lung cancer R&D

NEXT ARTICLE

More From BioPortfolio on "Daiichi, Merck subsidiary partner on breast, lung cancer R&D"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...